Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia Spectrum and Other Psychotic Disorders

Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.

3,091 public trials 348 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Completed

A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

NCT01678755

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Site Reference ID/Investigator# 74436 Chino, California, United States
  • Site Reference ID/Investigator# 72704 Garden Grove, California, United States
  • Site Reference ID/Investigator# 72699 National City, California, United States
  • Site Reference ID/Investigator# 73983 Oceanside, California, United States
View all 20 locations
View Trial Details
Completed

A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia

NCT04136873

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Pillar Clinical Research Bentonville, Arkansas, United States
  • Woodlands International Research Group Little Rock, Arkansas, United States
  • Synergy San Diego Lemon Grove, California, United States
  • Collaborative Neuroscience Network, LLC Long Beach, California, United States
View Trial Details
Completed

Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

NCT03064776

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • 3Department of Psychiatry and Psychotherapy, Semmelweis University Budapest, Hungary
  • The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center Tel Aviv, Israel
  • Department of Psychiatry. Hospital Santa Creu i Sant Pau Barcelona, Spain
View Trial Details
Completed

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

NCT03325556

Conditions
Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +39 more
Locations
  • ATP Clinical Research Inc. Costa Mesa, California, United States
  • Neurology Center of North Orange County Fullerton, California, United States
  • Visionary Investigators Network (Aventura Neurologic Associates) Aventura, Florida, United States
  • Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States
View all 83 locations
View Trial Details

Related conditions